Astellas Pharma Inc. (ALPMY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Astellas Pharma Inc.

    OTC: ALPMY · Real-Time Price · USD
    11.03
    -0.11 (-0.99%)
    At close: Oct 03, 2025, 3:59 PM
    11.02
    -0.09%
    After-hours: Oct 03, 2025, 03:59 PM EDT

    Astellas Pharma Cash Flow Statement

    Financials in JPY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Net Income
    		 31.24B 17.05B 98.71B 124.09B 120.59B
    Depreciation & Amortization
    		 199.13B 157.84B 105.74B 79.68B 72.65B
    Stock-Based Compensation
    		 n/a n/a n/a n/a n/a
    Other Working Capital
    		 -11.41B 29.47B 98.19B -16.64B 47.39B
    Other Non-Cash Items
    		 130.51B 84.11B 53.89B 65.07B 98.98B
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a
    Change in Working Capital
    		 -166.37B -86.52B 73.98B -10.68B 15.66B
    Operating Cash Flow
    		 194.51B 172.47B 332.32B 258.16B 307.88B
    Capital Expenditures
    		 -57.33B -82.5B -88.54B -76.45B -77.44B
    Cash Acquisitions
    		 n/a -784.97B n/a -229M -8.09B
    Purchase of Investments
    		 n/a n/a n/a -5.58B n/a
    Sales Maturities Of Investments
    		 12.92B n/a 12.62B 5.58B n/a
    Other Investing Acitivies
    		 -65.34B -22.77B -13.14B 13.55B 2.6B
    Investing Cash Flow
    		 -89.42B -845.8B -89.06B -63.13B -82.93B
    Debt Repayment
    		 -88.52B 771.23B -15B -60B -126B
    Common Stock Repurchased
    		 -6.96B -10.73B -60.56B -50.72B -9.16B
    Dividend Paid
    		 -128.99B -116.65B -100.36B -85.24B -76.16B
    Other Financial Acitivies
    		 -36.89B -29.79B -19.71B -20.34B -18.16B
    Financial Cash Flow
    		 -261.37B 614.06B -195.62B -216.3B -229.48B
    Net Cash Flow
    		 -147.31B -41.15B 60.85B -10.14B 7.74B
    Free Cash Flow
    		 137.18B 89.98B 243.78B 181.71B 230.44B

    Add to Watchlist